Cannell Capital’s TScan Therapeutics TCRX Stock Holding History

Cannell Capital’s Portfolio TCRX Stock Details TCRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$30.8K	Hold
2022 Q4	$22.7K	Hold
2022 Q3	$45K	Buy
2022 Q2	$11K	Buy